相关实验视频

Updated: Jan 13, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

在设计和计算阐释假设的白醇-黄素混合体作为潜在的癌症途径调节器

Nil Sazlı¹, Deniz Karataş¹

¹Bioengineering Department, Manisa Celal Bayar University, Yunusemre, Manisa 45140, Turkey.

Pharmaceuticals (Basel, Switzerland)

|October 29, 2025

概括

结合黄素和白醇的新混合分子通过向AKT1,MAPK和STAT3等关键信号通路,显示出增强的抗癌活性. 这些新型化合物克服了其母分子的药理动力学限制,提供了有前途的治疗潜力.

科学领域:

药用化学医学化学
计算生物学计算生物学
药理学药理学是指药理学的学科.

背景情况:

癌症的进展包括亡抑制,转移激活和不受控制的细胞增殖.
像PI3K/Akt/mTOR,MAPK和STAT3这样的关键信号通路调节这些癌症特征.
黄素和白醇具有抗癌性质,但具有较差的生物利用性和溶解性.

研究的目的:

设计和评估黄素和白醇的新型混合分子.
为了克服黄素和白醇的药理动力学限制.
使用in silico方法分析这些杂交物对AKT1,MAPK和STAT3通路的多目标抗癌作用.

主要方法:

使用阿沃加德罗软件设计的混合分子 (ELRC-LC,ELRC-SC,EtLRC).
使用密度函数理论 (DFT) 的几何优化和电子属性分析.
对AKT1,MAPK和STAT3受体进行分子对接,然后进行分子动力学 (MD) 模拟和MM/PBSA分析.

主要成果:

DFT分析证实了设计混合动力车的稳定电子特性.
分子对接显示,与母化合物相比,混合物具有更高的结合亲和力.
对于AKT1.1,ELRC-LC混合体的结合能是-11.4 kcal/mol,相对于AKT1.1,它的结合能是显著的.
MD模拟证实了混合受体复合体的结构稳定性.

结论:

设计的混合分子对AKT1,MAPK和STAT3通路具有多目标作用.
这些混合物通过克服药理动力学挑战,显示出作为抗癌剂的潜力.
这项研究为未来对这些新型混合抑制剂的体外和体内研究提供了基础.

关键词:

癌症信号通路是癌症的信号通路.这是一种de novo黄素 - 复星的混合物.在的药物设计中.分子建模分子建模结构性和药物动力学性质.

更多相关视频

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...